5 Einträge gefunden

1. Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines

   1. Press, Michael F
   2. Seoane, Jose A
   3. Curtis, Christina
   4. Quinaux, Emmanuel
   5. Guzman, Roberta
   6. Sauter, Guido
   7. Eiermann, Wolfgang

   2019 - Forschungsinformationssystem des UKE
2. Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial.

   1. Eiermann, Wolfgang
   2. Pienkowski, Tadeusz
   3. Crown, John
   4. Sadeghi, Saeed
   5. Martin, Miguel
   6. Chan, Arlene
   7. Saleh, Mansoor

   2011 - Forschungsinformationssystem des UKE
3. Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.

   1. Press, Michael F
   2. Sauter, Guido
   3. Buyse, Marc
   4. Bernstein, Leslie
   5. Guzman, Roberta
   6. Santiago, Angela
   7. Villalobos, Ivonne E

   2011 - Forschungsinformationssystem des UKE
4. Adjuvant trastuzumab in HER2-positive breast cancer.

   1. Slamon, Dennis
   2. Eiermann, Wolfgang
   3. Robert, Nicholas
   4. Pienkowski, Tadeusz
   5. Martin, Miguel
   6. Press, Michael
   7. Mackey, John

   2011 - Forschungsinformationssystem des UKE
5. Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active therapeutic regimens.

   1. Valero, Vicente
   2. Forbes, John
   3. Pegram, Mark D
   4. Pienkowski, Tadeusz
   5. Eiermann, Wolfgang
   6. von Minckwitz, Gunter
   7. Roche, Henri

   2011 - Forschungsinformationssystem des UKE